C

Centro Internacional de Estudios Clinicos | Santiago, Chile

Research site
(Unclaimed)
Location
Manzano 343 of 410, Santiago, Región Metropolitana de Santiago, Chile

Site insights

Top conditions

Top treatments

Rocatinlimab
AMG 451
MK-6194
MK-6194-007

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of MK-6194 in participants with non-segmental vitiligo. The primary h...

Enrolling
Non-segmental Vitiligo
Biological: MK-6194
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of MK-6194 in adult participants with Systemic Lupus Erythematosus. The primary hypo...

Enrolling
Systemic Lupus Erythematosus
Biological: MK-6194
Biological: Placebo

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems